91 related articles for article (PubMed ID: 2678636)
1. The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts.
Ramrakha PS; Sharp RJ; Yeoman H; Stanley MA
Transplantation; 1989 Oct; 48(4):676-80. PubMed ID: 2678636
[TBL] [Abstract][Full Text] [Related]
2. Rejection of MHC incompatible, Langerhans cell-free epidermal keratinocyte allografts in the rat.
Yeoman H; Munro AJ; Stanley MA
Reg Immunol; 1990; 3(2):75-81. PubMed ID: 2088475
[TBL] [Abstract][Full Text] [Related]
3. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
4. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
5. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
Tanaka K; Sonoda K; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
Yamada J; Hamuro J; Terai K; Kinoshita S
Transplantation; 2007 Oct; 84(7):899-907. PubMed ID: 17984844
[TBL] [Abstract][Full Text] [Related]
8. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
9. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA
Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710
[TBL] [Abstract][Full Text] [Related]
10. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
[TBL] [Abstract][Full Text] [Related]
12. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
13. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
15. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
16. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
Rouabhia M; Germain L; Bélanger F; Auger FA
Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
[TBL] [Abstract][Full Text] [Related]
17. Antigen presenting function of class II MHC expressing pancreatic beta cells.
Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem.
Silvers WK; Bartlett ST; Chen HD; Fleming HL; Naji A; Barker CF
Transplantation; 1984 Jan; 37(1):28-32. PubMed ID: 6364484
[TBL] [Abstract][Full Text] [Related]
19. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
20. Survival of deoxyguanosine-treated fetal thymus allografts is prevented by priming with dendritic cells.
Benson MT; Buckley G; Jenkinson EJ; Owen JJ
Immunology; 1987 Apr; 60(4):593-6. PubMed ID: 2953671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
